Additional sequencing for the alzheimer disease sequencing project (adsp) the follow-up study (FUS), the diverse population initiative

Active Cooperative Agreement Awarded Last action

Award ID
U01AG076482
Recipient
Awarding agency
Obligated
$41,208,913

Award facts

Assistance listing
93.866 Aging Research
Completion date 69% complete
Originally
Place of performance
Miami, FL 33136, USA

Award details come from USAspending.gov.

Description

Abstract
The alzheimer's disease sequencing project (adsp) is a national sequencing initiative focused on identifying genetic risk factors for ad. The project's discovery phase includes whole exome sequencing (WES) of 10,061 unrelated non-white hispanic individuals of european ancestry (NHW-EA) cases (n=5,096) and controls (n=4,965), and whole genome sequencing (WGS) of 584 NHW and hispanic/latino (HL) familial samples. The 'discovery extension phase' of the project added WGS on ~430 additional familial samples. The adsp follow- up study 1.0 (adsp-FUS 1.0) phase focused on examining candidate variants from the discovery phase, and identification of novel variants through combined analysis of diverse datasets, is ongoing. Its aim is to sequence existing cohorts with unrelated ad cases that 'encompass the richest possible ethnic diversity' as well as highly valuable set of autopsy confirmed cases and controls. In total we have already included in FUS over 50,000 samples for sequencing including >4,700 autopsy confirmed cases and controls, >9,400 HL ancestry cases and controls and > 8,300 african ancestry (AA) cases and controls. In this adsp-FUS 2.0 application, which focuses on the PAR-21-212 goal to increase diversity cohorts in the adsp with WGS, we are proposing sequencing, QC and phenotype harmonization of an additional ~16,000 individuals (~12,000 HL ancestry, 500 autopsied NHW-EA, ~3,400 AA and ~170 asian ancestry individuals) that will both increase our power to find effects and will also enhance our ability to find genetic effects in underserved groups. Additionally, these datasets will become an invaluable resource for the ad research community at-large.

Transactions

Action Obligated Date
Amendment $6,351,051
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $6,545,108
Amendment $0
Amendment $0
Amendment $6,942,173
Amendment $6,942,173
Amendment $17,283
Amendment $17,283
Amendment $17,283
Amendment $17,283
Amendment $108,473
Amendment $108,473
Amendment $108,473
Amendment $108,473
Amendment $6,962,692
Original award $6,962,692
Show all 20

Subawards

Subrecipient Amount Awarded
Trustees Of The University Of Pennsylvania AWD-008179: FUSing Around Again 09/01/2022 (version 3) $471,946
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. AWD-008179: FUSing Around Again 09/01/2022 $2,625,609
The Trustees Of Columbia University In The City Of New York $352,904
Trustees Of Indiana University AWD-008179: FUSing Around Again 09/01/2022 (version 3) $72,091
The Cleveland Clinic Foundation $241,492

Quick answers

Who received award U01AG076482?

U01AG076482 was awarded to University Of Miami by National Institute on Aging (National Institutes of Health) on September 1, 2022.

How much is award U01AG076482 worth?

$41,208,913 has been obligated on U01AG076482.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award